SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+46.32%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$670M
AUM Growth
+$670M
(+16%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
80
New
17
Increased
16
Reduced
32
Closed
15
Top Buys
| 1 |
Aprea Therapeutics
APRE
|
$67.5M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$16.5M |
| 3 |
Boston Scientific
BSX
|
$13.4M |
| 4 |
Teleflex
TFX
|
$10.9M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$10M |
Top Sells
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
$21.9M |
| 2 |
Teladoc Health
TDOC
|
$19M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$17.2M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$16.6M |
| 5 |
Amicus Therapeutics
FOLD
|
$13.5M |
Sector Composition
| 1 | Healthcare | 80.45% |
| 2 | Industrials | 5.08% |
| 3 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aprea Therapeutics
APRE
$9.09M
| $67.5M | 10.07% | +1,470,339 | New | +$67.5M |
|
|
2
Teladoc Health
TDOC
$1.37B
| $25M | 3.73% | 298,692 -226,819 | -43% | -$19M |
|
|
3
Boston Scientific
BSX
$156B
| $23.4M | 3.5% | 518,376 +296,200 | +133% | +$13.4M |
|
4
Tandem Diabetes Care
TNDM
$845M
| $20.4M | 3.04% | 341,714 -91,101 | -21% | -$5.43M |
|
|
5
Amicus Therapeutics
FOLD
$2.34B
| $20.1M | 2.99% | 2,059,961 -1,381,961 | -40% | -$13.5M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $18.9M | 2.82% | 223,901 +82,100 | +58% | +$6.94M |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $18.1M | 2.7% | 748,597 -342,937 | -31% | -$8.29M |
|
8
Evolent Health
EVH
$1.12B
| $18.1M | 2.7% | 1,999,172 +413,420 | +26% | +$3.74M |
|
9
AtriCure
ATRC
$1.84B
| $17.4M | 2.59% | 533,756 +86,301 | +19% | +$2.81M |
|
|
RETA
10
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $16.5M | 2.46% | +80,650 | New | +$16.5M |
|
11
PTC Therapeutics
PTCT
$3.92B
| $15.8M | 2.36% | 328,738 -48,500 | -13% | -$2.33M |
|
12
FibroGen
FGEN
$47.8M
| $15.7M | 2.35% | 366,806 +33,346 | +10% | +$1.43M |
|
13
Collegium Pharmaceutical
COLL
$1.22B
| $15.6M | 2.33% | 757,847 -147,400 | -16% | -$3.03M |
|
14
Inspire Medical Systems
INSP
$2.77B
| $15.2M | 2.27% | 205,000 -58,100 | -22% | -$4.31M |
|
|
RCM
15
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15M | 2.24% | 1,159,073 +169,501 | +17% | +$2.2M |
|
|
IMMU
16
DELISTED
Immunomedics Inc
IMMU
| $14.6M | 2.19% | 692,123 -217,699 | -24% | -$4.61M |
|
|
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.5M | 2.16% | 606,189 +59,700 | +11% | +$1.43M |
|
18
Assembly Biosciences
ASMB
$190M
| $14.2M | 2.11% | 692,700 -27,196 | -4% | -$556K |
|
19
Bristol-Myers Squibb
BMY
$96B
| $14.1M | 2.1% | 219,474 -61,123 | -22% | -$3.92M |
|
|
20
Apellis Pharmaceuticals
APLS
$3.48B
| $13.9M | 2.08% | 455,393 -541,590 | -54% | -$16.6M |
|
|
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $13.9M | 2.08% | 122,599 +34,500 | +39% | +$3.92M |
|
|
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13.9M | 2.07% | 174,594 -66,446 | -28% | -$5.28M |
|
|
VCRA
23
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $12.2M | 1.81% | 585,528 +106,800 | +22% | +$2.22M |
|
|
24
Teleflex
TFX
$5.59B
| $10.9M | 1.63% | +29,057 | New | +$10.9M |
|
|
STML
25
DELISTED
Stemline Therapeutics, Inc.
STML
| $10.9M | 1.62% | 1,023,159 +345,400 | +51% | +$3.67M |
|